Compile Data Set for Download or QSAR
Report error Found 10 of ic50 for monomerid = 313781
TargetBromodomain-containing protein 4(Human)
Walter and Eliza Hall Institute of Medical Research

Curated by ChEMBL
LigandPNGBDBM313781(US10167292, Example 21)
Affinity DataIC50: 36nMAssay Description:Inhibition of human His-tagged Brd4 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinyla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetBromodomain-containing protein 3(Human)
Walter and Eliza Hall Institute of Medical Research

Curated by ChEMBL
LigandPNGBDBM313781(US10167292, Example 21)
Affinity DataIC50: 44nMAssay Description:Inhibition of human His-tagged Brd3 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinyla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetBromodomain-containing protein 2(Human)
Walter and Eliza Hall Institute of Medical Research

Curated by ChEMBL
LigandPNGBDBM313781(US10167292, Example 21)
Affinity DataIC50: 45nMAssay Description:Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinyla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Walter and Eliza Hall Institute of Medical Research

Curated by ChEMBL
LigandPNGBDBM313781(US10167292, Example 21)
Affinity DataIC50: 52nMAssay Description:Inhibition of human His-tagged Brd4 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinyla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetBromodomain-containing protein 2 [364-436](Human)
Catalyst Therapeutics

US Patent
LigandPNGBDBM313781(US10167292, Example 21)
Affinity DataIC50: 100nMAssay Description:BRD binding and inhibition was assessed by measuring the interaction of biotinylated acetyl-histone H4 peptide (Anaspec #64989) with the BRD target p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent

TargetBromodomain-containing protein 3 [51-123](Human)
Catalyst Therapeutics

US Patent
LigandPNGBDBM313781(US10167292, Example 21)
Affinity DataIC50: 100nMAssay Description:BRD binding and inhibition was assessed by measuring the interaction of biotinylated acetyl-histone H4 peptide (Anaspec #64989) with the BRD target p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [75-147](Human)
Catalyst Therapeutics

US Patent
LigandPNGBDBM313781(US10167292, Example 21)
Affinity DataIC50: 100nMAssay Description:BRD binding and inhibition was assessed by measuring the interaction of biotinylated acetyl-histone H4 peptide (Anaspec #64989) with the BRD target p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [368-440](Human)
Catalyst Therapeutics

US Patent
LigandPNGBDBM313781(US10167292, Example 21)
Affinity DataIC50: 100nMAssay Description:BRD binding and inhibition was assessed by measuring the interaction of biotinylated acetyl-histone H4 peptide (Anaspec #64989) with the BRD target p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent

TargetBromodomain-containing protein 2(Human)
Walter and Eliza Hall Institute of Medical Research

Curated by ChEMBL
LigandPNGBDBM313781(US10167292, Example 21)
Affinity DataIC50: 340nMAssay Description:Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinyla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetBromodomain-containing protein 2 [91-163](Human)
Catalyst Therapeutics

US Patent
LigandPNGBDBM313781(US10167292, Example 21)
Affinity DataIC50: 550nMAssay Description:BRD binding and inhibition was assessed by measuring the interaction of biotinylated acetyl-histone H4 peptide (Anaspec #64989) with the BRD target p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent